Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Show other versions (1)

Primaquine (PQ) kills Plasmodium vivax hypnozoites but can cause severe hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. We conducted two systematic reviews. The first used data from clinical trials to determine the variety of definitions and frequency of hematological...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Yilma, D, Groves, ES, Brito-Sousa, JD, Monteiro, WM, Chu, C, Thriemer, K, Commons, RJ, Lacerda, MVG, Price, RN, Douglas, NM
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	American Society of Tropical Medicine and Hygiene 2023

Eitemau Tebyg

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
gan: Yilma, D, et al.
Cyhoeddwyd: (2021)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
gan: Price, RN, et al.
Cyhoeddwyd: (2018)

Primaquine for plasmodium vivax malaria treatment – authors' reply
gan: Price, RN, et al.
Cyhoeddwyd: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
gan: Setyadi, A, et al.
Cyhoeddwyd: (2019)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
gan: John, G, et al.
Cyhoeddwyd: (2012)

Plasmodium vivax in the era of the shrinking P. falciparum map
gan: Price, RN, et al.
Cyhoeddwyd: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
gan: Watson, JA, et al.
Cyhoeddwyd: (2022)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
gan: Thriemer, K, et al.
Cyhoeddwyd: (2020)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
gan: Taylor, WRJ, et al.
Cyhoeddwyd: (2023)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
gan: Watson, JA, et al.
Cyhoeddwyd: (2024)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
gan: Abla, N, et al.
Cyhoeddwyd: (2024)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
gan: Nada Abla, et al.
Cyhoeddwyd: (2024-09-01)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
gan: Llanos-Cuentas, A, et al.
Cyhoeddwyd: (2019)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
gan: Commons, RJ, et al.
Cyhoeddwyd: (2018)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
gan: Rahmalia, A, et al.
Cyhoeddwyd: (2019)

Progress towards safer and more effective radical cure of Plasmodium vivax
gan: Price, RN
Cyhoeddwyd: (2024)

Improving the radical cure of Plasmodium vivax malaria.
gan: Price, R
Cyhoeddwyd: (2014)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
gan: Taylor, WRJ, et al.
Cyhoeddwyd: (2019)

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
gan: Fadilah, I, et al.
Cyhoeddwyd: (2024)

Treatment of primaquine-resistant Plasmodium vivax malaria.
gan: Luzzi, G, et al.
Cyhoeddwyd: (1992)

Primaquine as anti-relapse therapy for Plasmodium vivax
gan: Baird, J
Cyhoeddwyd: (1998)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
gan: Luzzi, G, et al.
Cyhoeddwyd: (1992)

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
gan: Commons, RJ, et al.
Cyhoeddwyd: (2023)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
gan: Rajasekhar, M, et al.
Cyhoeddwyd: (2023)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials.
gan: Commons, R, et al.
Cyhoeddwyd: (2017)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
gan: Pukrittayakamee, S, et al.
Cyhoeddwyd: (2010)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
gan: Douglas, NM, et al.
Cyhoeddwyd: (2017)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
gan: Mehdipour, P, et al.
Cyhoeddwyd: (2023)

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
gan: Thriemer, K, et al.
Cyhoeddwyd: (2022)

Primaquine-induced severe hemolysis in the absence of concomitant malaria: effects on G6PD activity and renal function
gan: Douglas, NM, et al.
Cyhoeddwyd: (2022)

Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
gan: Hamid, MMA, et al.
Cyhoeddwyd: (2018)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
gan: Poespoprodjo, JR, et al.
Cyhoeddwyd: (2021)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
gan: Kho, S, et al.
Cyhoeddwyd: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
gan: Watson, J, et al.
Cyhoeddwyd: (2018)

The WWARN Vivax Surveyor: Open access online mapping database for clinical trials of Plasmodium vivax
gan: Commons, R, et al.
Cyhoeddwyd: (2018)

Estimating the proportion of plasmodium vivax recurrences caused by relapse: A systematic review and meta-analysis
gan: Commons, RJ, et al.
Cyhoeddwyd: (2020)

Burden and clinical characteristics of recurrent Plasmodium vivax infections, and impact of primaquine for radical cure: a systematic scoping review in India
gan: Loick Pradel Kojom Foko, et al.
Cyhoeddwyd: (2024-12-01)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
gan: Baird, J
Cyhoeddwyd: (2018)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
gan: Watson, J, et al.
Cyhoeddwyd: (2019)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
gan: Baird, J, et al.
Cyhoeddwyd: (1995)